Resilience · 6 hours ago
Analyst II, Quality Control
USA - PA - East Norriton
Full-time
Onsite
Entry, Mid Level
$65K/yr - $91K/yr
2+ years expResilience is a technology-focused biomanufacturing company that’s changing the way medicine is made. The Analyst II, Quality Control role involves performing routine testing for manufacturing release and stability samples of gene and cell therapy products, ensuring compliance with established procedures and internal stakeholder needs.
BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
No H1B
Responsibilities
Perform routine sample analysis in support of manufacturing release and stability activities
Sample testing of manufactured products using protein-based assays, molecular methods, and cellular assays
Participate in method qualification/validation activities as necessary
Analyze, document, and report experimental data in accordance with Resilience requirements
Maintain, calibrate, and operate analytical equipment
Qualify equipment related to testing
Document work in accordance with cGMPs, established business processes and applicable SOPs
Author SOPs, methods, protocols, training materials, and reports in alignment with applicable cGMPs, business standards, and intended use
Own, author, and support QC change controls for the East Norriton site, as applicable
Other activities as assigned
Qualification
Required
Experience in mammalian cell culture
Knowledge of general analytical methods
Successful visual acuity test required for this role
Preferred
BS in relevant discipline (immunology, cell biology, or related field)
2 or more years relevant life science experience
GMP Experience preferred
Benefits
Annual cash bonus program
401(k) plan with a generous company match
Great healthcare (including medical, dental and vision)
Family building benefits
Life and disability insurance
Flexible time off
Paid holidays
Other paid leaves of absence
Tuition reimbursement
Support for caregiving needs
Company
Resilience
Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
1001-5000 employees
Funding
Current Stage
Late StageTotal Funding
$3.36BKey Investors
Oak Hill AdvisorsAdministration for Strategic Preparedness and ResponseMubadala
2025-10-29Debt Financing· $825M
2024-10-03Grant· $17.5M
2023-03-24Debt Financing· $410M
Leadership Team
William Marth
President & Chief Executive Officer
Susan Billings
Chief Commercial Officer (CCO)
Recent News
Help Net Security
2025-11-11
2025-11-05
Company data provided by crunchbase